Bone and joint infections (BJI), although infrequent (prevalence of 70 per 100,000 in France), have a significant economic and clinical impact. Between 2008 and 2013, the prevalence of BJI increased and infections involving joint prosthesis (PJI) represent a third of BJI in France. They are most often post-operative and more expensive than native IOAs. This study aims to describe PJI and understand the failure mechanisms of PJI in order to improve their management.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
rate of PJI
Timeframe: between 2018 and 2020
Description of PJI
Timeframe: between 2018 and 2020
Description of type of prosthesis PJI
Timeframe: between 2018 and 2020
Description of patients having had a PJI
Timeframe: between 2018 and 2020
Description of comorbidities of patients having had a PJI
Timeframe: between 2018 and 2020
rate of bacteria
Timeframe: between 2018 and 2020
description of antibiotic used
Timeframe: between 2018 and 2020
description of antibiotic treatment
Timeframe: between 2018 and 2020
description of surgical treatment
Timeframe: between 2018 and 2020